AGED MEN

Y chromosome loss in men with age linked with worse cancer outcomes

In this study, reviewing data on two groups of men, the researchers found that men with muscle invasive bladder cancer not being treated and thus, losing Y chromosomes, had poorer prognosis and lower survival rates compared to those being treated with an immune checkpoint inhibitor, a form of treatment used by the researchers once they found that the cancer was responsive to it.